CIA
IBB icon

Capital Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Capital Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Sell
8,455
-145
-2% -$24.8K 0.02% 290
2025
Q4 		$1.45M Sell
8,600
-69
-0.8% -$11.2K 0.02% 282
2025
Q3 		$1.25M Sell
8,669
-364
-4% -$49.7K 0.02% 304
2025
Q2 		$1.14M Sell
9,033
-804
-8% -$98.7K 0.02% 315
2025
Q1 		$1.26M Sell
9,837
-612
-6% -$83K 0.02% 290
2024
Q4 		$1.38M Buy
10,449
+99
+1% +$13.9K 0.03% 264
2024
Q3 		$1.51M Sell
10,350
-472
-4% -$68.3K 0.03% 255
2024
Q2 		$1.49M Sell
10,822
-83
-0.8% -$11.1K 0.03% 242
2024
Q1 		$1.5M Sell
10,905
-359
-3% -$49K 0.03% 233
2023
Q4 		$1.53M Buy
11,264
+108
+1% +$13.2K 0.04% 224
2023
Q3 		$1.36M Sell
11,156
-827
-7% -$105K 0.04% 222
2023
Q2 		$1.52M Sell
11,983
-2
-0% -$260 0.05% 192
2023
Q1 		$1.55M Sell
11,985
-141
-1% -$18.5K 0.05% 194
2022
Q4 		$1.59M Sell
12,126
-633
-5% -$81.8K 0.05% 197
2022
Q3 		$1.49M Sell
12,759
-420
-3% -$52.2K 0.05% 201
2022
Q2 		$1.55M Sell
13,179
-230
-2% -$27.3K 0.05% 205
2022
Q1 		$1.75M Sell
13,409
-421
-3% -$54.8K 0.05% 205
2021
Q4 		$2.11M Sell
13,830
-774
-5% -$120K 0.06% 189
2021
Q3 		$2.36M Sell
14,604
-254
-2% -$42.7K 0.08% 171
2021
Q2 		$2.43M Sell
14,858
-463
-3% -$71.3K 0.08% 171
2021
Q1 		$2.31M Buy
15,321
+940
+7% +$149K 0.09% 161
2020
Q4 		$2.18M Sell
14,381
-165
-1% -$23.6K 0.09% 154
2020
Q3 		$1.97M Buy
14,546
+3,323
+30% +$451K 0.09% 156
2020
Q2 		$1.53M Buy
11,223
+850
+8% +$108K 0.08% 163
2020
Q1 		$1.12M Sell
10,373
-453
-4% -$52.2K 0.07% 180
2019
Q4 		$1.3M Sell
10,826
-885
-8% -$98.7K 0.06% 197
2019
Q3 		$1.17M Buy
11,711
+381
+3% +$39.9K 0.06% 207
2019
Q2 		$1.24M Buy
11,330
+816
+8% +$86.8K 0.07% 199
2019
Q1 		$1.18M Sell
10,514
-1,423
-12% -$156K 0.07% 200
2018
Q4 		$1.15M Buy
11,937
+420
+4% +$44.6K 0.08% 192
2018
Q3 		$1.4M Sell
11,517
-62
-0.5% -$7.3K 0.08% 173
2018
Q2 		$1.27M Buy
11,579
+585
+5% +$62.6K 0.08% 183
2018
Q1 		$1.17M Buy
10,994
+710
+7% +$78.7K 0.08% 194
2017
Q4 		$1.1M Buy
10,284
+570
+6% +$60.9K 0.07% 202
2017
Q3 		$1.08M Buy
9,714
+456
+5% +$48.7K 0.07% 197
2017
Q2 		$957K Buy
9,258
+192
+2% +$18.9K 0.07% 212
2017
Q1 		$886K Sell
9,066
-33
-0.4% -$3.16K 0.07% 220
2016
Q4 		$805K Buy
9,099
+1,806
+25% +$164K 0.07% 222
2016
Q3 		$704K Sell
7,293
-105
-1% -$9.99K 0.06% 232
2016
Q2 		$635K Sell
7,398
-5,988
-45% -$537K 0.06% 231
2016
Q1 		$1.16M Sell
13,386
-44,436
-77% -$3.97M 0.11% 159
2015
Q4 		$6.52M Sell
57,822
-2,172
-4% -$236K 0.67% 35
2015
Q3 		$6.07M Sell
59,994
-894
-1% -$107K 0.68% 35
2015
Q2 		$7.49M Sell
60,888
-1,671
-3% -$200K 0.81% 27
2015
Q1 		$7.16M Buy
62,559
+1,377
+2% +$152K 0.76% 29
2014
Q4 		$6.19M Sell
61,182
-1,104
-2% -$107K 0.68% 37
2014
Q3 		$5.68M Sell
62,286
-2,196
-3% -$193K 0.65% 40
2014
Q2 		$5.53M Sell
64,482
-2,349
-4% -$185K 0.63% 40
2014
Q1 		$5.27M Sell
66,831
-2,100
-3% -$175K 0.66% 38
2013
Q4 		$5.22M Buy
+68,931
New +$4.89M 0.69% 37

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Investment Advisors's IBB Position: Q1 2026 in Review

Capital Investment Advisors reduced its iShares Biotechnology ETF (IBB) stake by 1.7% in Q1 2026, selling an estimated $24.8K and leaving 8,455 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #290.

Capital Investment Advisors first reported a position in IBB in Q4 2013 and has held it in 50 quarters since. The position peaked at $7.49M in Q2 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Capital Investment Advisors held 8,455 shares of iShares Biotechnology ETF worth $1.43M as of Q1 2026.
  • Capital Investment Advisors sold 145 iShares Biotechnology ETF shares in Q1 2026, an estimated $24.8K.
  • iShares Biotechnology ETF made up 0.02% of Capital Investment Advisors's portfolio in Q1 2026, its #290 holding.
  • Capital Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 50 quarters since.
  • Capital Investment Advisors's iShares Biotechnology ETF position peaked at $7.49M in Q2 2015.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.